Is rectal indomethacin effective in preventing of post-endoscopic retrograde cholangiopancreatography pancreatitis?

doi:10.3748/wjg.v20.i29.10151

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 20, Issue 29

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5998)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Tables (1-4) series.

Item

Count

PDF

527

WORD

261

HTML

3242

Tables (1-4)

125

Sum=4155

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

927

Download

916

Sum=1843

Aug 7, 2014 (publication date) through Apr 25, 2024

Times Cited of This Article

Times Cited (46)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Randomized Controlled Trial

World J Gastroenterol. Aug 7, 2014; 20(29): 10151-10157
Published online Aug 7, 2014. doi: 10.3748/wjg.v20.i29.10151

Table 4 Incidence of post-endoscopic retrograde cholangiopancreatography pancreatitis according to risk factors (n = 665) n (%)

Risk factors	Indomethacingroup	Control group	P value
Age < 50 yr (n = 104)	5/57 (8.77)	6/47 (12.76)	0.365
Female gender (n = 426)	16/214 (7.47)	19/212 (8.96)	0.576
BMI > 25 (n = 362)	12/191 (6.28)	10/171 (5.85)	0.862
Duration of ERCP > 20 min (n = 211)	8/111 (7.2)	7/100 (7.0)	0.580
Non-dilated bile duct (n = 299)	10/158 (6.33)	11/141 (7.8)	1.000
Pancreatic duct opacification (n = 463)	20/246 (8.13)	20/217 (9.21)	0.263
EST biliary (n = 443)	14/224 (6.25)	14/219 (6.4)	0.951
EST pancreatic/double (n = 48)	4/20 (20.0)	5/28 (17.86)	0.560
Difficult cannulation (n = 116)	4/64 (6.25)	6/52 (11.54)	0.478
Gallstone extraction (n = 165)	3/82 (3.66)	5/83 (6.02)	0.451
Bile duct dilatation (n = 22)	1/11 (9.1)	2/11 (18.2)	0.537
Biliary plastic stent placement (n = 75)	4/35 (11.43)	3/40 (7.5)	0.580

There were no statistically significant differences. BMI: Body mass index; EST: Endoscopic sphincterotomy; ERCP: Endoscopic retrograde cholangiopancreatography.

Citation: Döbrönte Z, Szepes Z, Izbéki F, Gervain J, Lakatos L, Pécsi G, Ihász M, Lakner L, Toldy E, Czakó L. Is rectal indomethacin effective in preventing of post-endoscopic retrograde cholangiopancreatography pancreatitis? World J Gastroenterol 2014; 20(29): 10151-10157
URL: https://www.wjgnet.com/1007-9327/full/v20/i29/10151.htm
DOI: https://dx.doi.org/10.3748/wjg.v20.i29.10151